ArticleCardio-oncology (London, England)2025
Trends and disparities in chronic ischemic heart disease mortality among adult cancer patients: a nationwide CDC WONDER analysis (1999-2020).
Article in Cardio-oncology (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Global trends in ischemic heart disease among older adults (> 60 Years): analysis of epidemiological patterns and disease burden from 1990 through 2021.Journal of cardiothoracic surgery · 2026Article
- Trends and disparities in deaths involving atherosclerotic cardiovascular disease and stroke-related conditions among U.S. adults, 1999-2025.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic ischemic heart disease (IHD) is a leading cause of cardiovascular-related mortality worldwide, with a growing burden among cancer patients due to shared risk factors and treatment-related Cardiotoxicity. However, nationwide trends and disparities in IHD-related mortality among cancer patients remain unexplored. METHODOLOGY: This study utilized CDC WONDER mortality data from 1999 to 2020, identifying U.S. adults (≥ 25 years) with cancer (ICD-10: C00-D48) who died from chronic IHD (ICD-10: I25) as the underlying cause. Age-adjusted mortality rates (AAMRs) and annual percent changes (APCs) were calculated and stratified by gender, age, race, geographic region, and urbanization level.
resultsBetween 1999 and 2020, there were 246,664 Chronic IHD-related deaths among adult cancer patients. The AAMR declined significantly from 8.44 per 100,000 in 1999 to 3.71 in 2020. A steady decline occurred from 1999 to 2018 (APC: -3.85%; 95% CI: -4.01 to -3.72), followed by a slight increase from 2018 to 2020 (APC: 2.92%; 95% CI: 0.33 to 4.70). Men had higher AAMRs than women (8.16 vs. 3.25). The highest CMR were observed in older adults (24.19), with significantly lower rates in middle-aged (1.26) and young adults (0.04). Racial disparities revealed the highest AAMRs in non-Hispanic Black individuals (5.64), followed by non-Hispanic Whites (5.37), NH American Indian (3.59), Hispanics (3.28), and NH Asians (2.7). Geographic trends showed that the Northeast had the highest AAMRs (6.88), while urban areas had slightly higher mortality than rural areas (5.23 vs. 5.06).
conclusionsThis nationwide analysis highlights a significant decline in chronic IHD-related mortality among cancer patients, with persistent disparities by gender, age, race, and geographic location. The recent rise in AAMRs after 2018 suggests emerging risk factors that warrant further investigation. Addressing these disparities through targeted cardiovascular risk management in cancer patients is crucial to improving long-term outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.